ICD-10 Coordination and Maintenance Committee Meeting Materials

The March 8-9, 2022 ICD-10 COORDINATION AND MAINTENANCE COMMITTEE MEETING will be fully virtual.

Consistent with the requirements of section 1886(d)(5)(K)(iii) of the Social Security Act applicants submitted requests to create a unique procedure code to describe the administration of a therapeutic agent, such as the option to create a new code in Section X within the ICD-10-PCS procedure code classification.  CMS will not be presenting these NTAP-related ICD-10-PCS procedure code requests that involve the administration of a therapeutic agent at the upcoming virtual meeting on March 8-9, 2022. The 13 NTAP related ICD-10-PCS procedure code requests that involve the administration of a therapeutic agent are:

1. Administration of Spesolimab 
2. Administration of daratumumab and hyaluronidase-fihj
3. Extracorporeal Antimicrobial Administration During Renal Replacement Therapy
4. Administration of Maribavir
5. Administration of Teclistamab
6. Administration of Mosunetuzumab
7. Administration of afamitresgene autoleucel
8. Administration of tabelecleucel
9. Administration of Treosulfan
10. Administration of inebilizumab-cdon
11. Hyperpolarized Xenon-129 Gas for Imaging of Lung Function
12. Administration of betibeglogene autotemcel
13. Administration of Omidubicel

CMS will be soliciting public comments regarding any clinical questions or coding options for the 13 listed procedure code topics related to new technology add-on payment (NTAP)-related ICD-10-PCS procedure code requests that involve the administration of a therapeutic agent in advance of the meeting continuing through the end of the public comment period. 

The deadline to submit comments for topics being considered for an October 1, 2022 implementation is April 8, 2022.  Members of the public should send any questions or comments to the CMS mailbox at: ICDProcedureCodeRequest@cms.hhs.gov  by the designated deadline.

Prior to the meeting, CMS will post a question and answer document to address clinical or coding questions that members of the public have submitted related to the 13 therapeutic agents.  At a later date, CMS will post an updated question and answer document to address any additional clinical or coding questions that members of the public may have submitted by the April 8, 2022 deadline.

CMS will present the NTAP-related ICD-10-PCS procedure code requests that do not involve the administration of a therapeutic agent and all non-NTAP-related procedure code requests during the virtual meeting on March 8, 2022, consistent with the standard meeting process.

CMS will make all meeting materials and related documents available below.  Any inquiries related to the procedure code topics scheduled for the March 8-9, 2022 ICD-10 Coordination and Maintenance Committee meeting that are under consideration for an October 1, 2022 implementation should be sent to the CMS mailbox at: ICDProcedureCodeRequest@cms.hhs.gov by the designated deadline.
 

Below are the meeting materials for the procedure code issues listed by date of the scheduled meetings. These materials include the Agenda and Materials, as well as any slides or other files made available.

Presentations for procedure code requests are conducted by both the requestor and CMS during the C&M meeting. Discussion from the requestor generally focuses on the clinical issues for the procedure or technology, followed by the proposed coding options from a CMS analyst. Topics presented may also include requests for new procedure codes that relate to a new technology add-on payment (NTAP) request.